Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.
The company today said it proposes offer for sale of $250 million of shares.
DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.
Source: Read Full Article
Lates News:
-
Bitcoin Price Could Easily Double Under CFTC-Led Regulation, Chair Rostin Behnam Reckons
-
BTC Developer Says: 2024 Bitcoin Core Update to Disrupt Ordinals and BRC-20 Tokens
-
Binance Secures First Full Crypto Exchange Licenses in El Salvador
-
Bowlero Corp. Slips 8% Following Q1 Results
-
Bitcoin Could See Santa Claus Rally Before Moving to $65,000 Next Year, Says Analyst Who Called 2018’s Market Bottom